Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
ZypAdhera ® (olanzapine pamoate monohydrate)
ZypAdhera® (olanzapine pamoate): Solvent for Reconstitution
Reconstitute olanzapine pamoate powder for prolonged release suspension for injection only with the solvent provided in the pack using standard aseptic techniques for reconstitution of parenteral products.
This medicinal product must not be mixed with other medicinal products except the solvent provided in the pack.1
It is recommended that gloves are used as olanzapine pamoate may irritate the skin.1
1. ZypAdhera [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Date of Last Review: January 24, 2021